Megace en es it fr

Megace Brand names, Megace Analogs

Megace Brand Names Mixture

  • No information avaliable

Megace Chemical_Formula

C7H7NO3

Megace RX_link

http://www.rxlist.com/cgi/generic2/canasa.htm

Megace fda sheet

Megace FDA

Megace msds (material safety sheet)

Megace MSDS

Megace Synthesis Reference

No information avaliable

Megace Molecular Weight

153.135 g/mol

Megace Melting Point

283 oC

Megace H2O Solubility

0.84 g/L at 20°C

Megace State

Solid

Megace LogP

1.012

Megace Dosage Forms

Rectal suppository (500 mg or 1000 mg)

Megace Indication

For the treatment of active ulcerative proctitis.

Megace Pharmacology

Sulfasalazine has been used in the treatment of ulcerative colitis for over 55 years. It is split by bacterial action in the colon into sulfapyridine (SP) and mesalamine (5-ASA). It is thought that the mesalamine component only is therapeutically active in ulcerative colitis.

Megace Absorption

20 to 30% absorbed following oral administration. 10 to 35% absorbed from the colon (rectal suppository) - extent of absorption is determined by the length of time the drug is retained in the colon.

Megace side effects and Toxicity

Oral, mouse: LD50 = 3370 mg/kg; Oral, rat: LD50 = 2800 mg/kg; Skin, rabbit: LD50 = >5 gm/kg. There have been no documented reports of serious toxicity in man resulting from massive overdosing with mesalamine. Under ordinary circumstances, mesalamine absorption from the colon is limited.

Megace Patient Information

Megace Organisms Affected

Humans and other mammals